MEN Type 1 (MEN1) Syndrome

Source: Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 3, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Childhood Multiple Endocrine Neoplasia (MEN) Syndromes

The treatment of patients with MEN1 syndrome is based on the type of tumor. The outcomes of patients with MEN1 syndrome are generally good, provided adequate treatment can be obtained for parathyroid, pancreatic, and pituitary tumors.

The standard approach to patients who present with hyperparathyroidism and MEN1 syndrome is genetic testing and treatment with a cervical resection of at least three parathyroid glands and transcervical thymectomy.[1]

Source links and citations

For more information, see the Interventions section in Genetics of Endocrine and Neuroendocrine Neoplasias.

Source links and citations

Interventions

Publication references

Read the original reference and check its publication notices.

PubMed 24726110 · Original source

Preserved source evidence · Not medical advice